Objective: To date, very few studies investigating neurocognitive deficits in COVID-19 have been published. This case series addresses cognition in post-COVID-19 patient by describing three patients in acute rehabilitation to inform a model of cognitive sequelae of COVID-19. Methods: Three English-speaking inpatients with severe symptoms and long-term intensive care unit (ICU) treatment are described. All patients had a premorbid history of hypertension and hyperlipidemia and experienced delirium and hypoxemia when hospitalized. Patient 1 is a 62-year-old male with 15 years of education with additional history of obstructive sleep apnea and type 2 diabetes. Patient 2 is a 73-year-old female with 12 years of education with a premorbid medical history of alcohol use disorder and Guillain-Barre syndrome. Patient 3 is a 75-year-old male with 14 years of education. No patients had premorbid psychiatric histories. Results: The three patients demonstrated deficits on formal neuropsychological testing, particularly with encoding and verbal fluency. Memory measures improved with a more structured story memory task compared to a less-structured verbal list-learning task, suggesting executive dysfunction impacted learning. None of the patients demonstrated rapid forgetting of information. Two patients endorsed new depressive and/or anxiety symptoms. Conclusions: The results suggest evidence for neurocognitive deficits after severe COVID-19 infection, particularly in encoding and verbal fluency. These results were interpreted with caution given the limited number of patients and the telephone-based battery. The specific mechanism that caused these cognitive deficits in these individuals remains unclear. A proposed three-stage model of cognitive dysfunction is described to help guide future research.
Objective: To date, very few studies investigating neurocognitive deficits in COVID-19 have been published. This case series addresses cognition in post-COVID-19patient by describing three patients in acute rehabilitation to inform a model of cognitive sequelae of COVID-19. Methods: Three English-speaking inpatients with severe symptoms and long-term intensive care unit (ICU) treatment are described. All patients had a premorbid history of hypertension and hyperlipidemia and experienced delirium and hypoxemia when hospitalized. Patient 1 is a 62-year-old male with 15 years of education with additional history of obstructive sleep apnea and type 2 diabetes. Patient 2 is a 73-year-old female with 12 years of education with a premorbid medical history of alcohol use disorder and Guillain-Barre syndrome. Patient 3 is a 75-year-old male with 14 years of education. No patients had premorbid psychiatric histories. Results: The three patients demonstrated deficits on formal neuropsychological testing, particularly with encoding and verbal fluency. Memory measures improved with a more structured story memory task compared to a less-structured verbal list-learning task, suggesting executive dysfunction impacted learning. None of the patients demonstrated rapid forgetting of information. Two patients endorsed new depressive and/or anxiety symptoms. Conclusions: The results suggest evidence for neurocognitive deficits after severe COVID-19infection, particularly in encoding and verbal fluency. These results were interpreted with caution given the limited number of patients and the telephone-based battery. The specific mechanism that caused these cognitive deficits in these individuals remains unclear. A proposed three-stage model of cognitive dysfunction is described to help guide future research.
Entities:
Keywords:
COVID-19; executive functioning; intensive care unit; memory; rehabilitation
Authors: Rosalia Dacosta-Aguayo; Noemí Lamonja-Vicente; Carla Chacón; Lucia Amalía Carrasco-Ribelles; Pilar Montero-Alia; Anna Costa-Garrido; Rosa García-Sierra; Victor M López-Lifante; Eduard Moreno-Gabriel; Marta Massanella; Josep Puig; Jose A Muñoz-Moreno; Lourdes Mateu; Anna Prats; Carmina Rodríguez; Maria Mataró; Julia G Prado; Eva Martínez-Cáceres; Concepción Violán; Pere Torán-Monserrat Journal: Vaccines (Basel) Date: 2022-05-26
Authors: Adam Hampshire; Doris A Chatfield; Anne Manktelow MPhil; Amy Jolly; William Trender; Peter J Hellyer; Martina Del Giovane; Virginia F J Newcombe; Joanne G Outtrim; Ben Warne; Junaid Bhatti; Linda Pointon; Anne Elmer; Nyarie Sithole; John Bradley; Nathalie Kingston; Stephen J Sawcer; Edward T Bullmore; James B Rowe; David K Menon Journal: EClinicalMedicine Date: 2022-04-28
Authors: Carmen García-Sánchez; Marco Calabria; Nicholas Grunden; Catalina Pons; Juan Antonio Arroyo; Beatriz Gómez-Anson; Alberto Lleó; Daniel Alcolea; Roberto Belvís; Noemí Morollón; Isabel Mur; Virginia Pomar; Pere Domingo Journal: Brain Behav Date: 2022-02-08 Impact factor: 2.708